Strata Skin Sciences
| Company type | Public |
|---|---|
| Nasdaq: MELA | |
| Founded | 1 January 1989  |
| Headquarters | Irvington, New York , United States |
| Website | melasciences.com |
MELA Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
The company’s flagship product, MelaFind®, is intended to be used when a trained dermatologist chooses to obtain additional information to help decide whether to biopsy certain clinically atypical pigmented skin lesions. Following completion of a successful conformity assessment procedure, MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.[1]
In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County.[2]
External links
References
- ^ "Case - Mela Sciences Inc". Pomeranz Law. Archived from the original on 17 November 2012. Retrieved 17 November 2012.
- ^ George, John. "Exclusive: N.Y. medical device firm moving to Montco" Philadelphia Business Journal (July 15, 2015)